Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

Anthrax vs. Cancer – Researchers Harness Deadly Toxin to Cure Dogs and Potentially People

Science

Dogs with terminal bladder cancer improved with a new modified anthrax treatment. pyotr021 / iStock / Getty Images Plus

By R. Claudio Aguilar

Can the feared anthrax toxin become an ally in the war against cancer? Successful treatment of pet dogs suffering bladder cancer with an anthrax-related treatment suggests so.


Anthrax is a disease caused a by bacterium, known as Bacillus anthracis, which releases a toxin that causes the skin to break down and forms ulcers, and triggers pneumonia and muscle and chest pain. To add to its sinister resumé, and underscore its lethal effects, this toxin has been infamously used as a bioweapon.

However, my colleagues and I found a way to tame this killer and put it to good use against another menace: bladder cancer.

I am a biochemist and cell biologist who has been working on research and development of novel therapeutic approaches against cancer and genetic diseases for more than 20 years. Our lab has investigated, designed and adapted agents to fight disease; this is our latest exciting story.

Pressing Needs

Among all cancers, the one affecting the bladder is the sixth most common and in 2019 caused more than 17,000 deaths in the U.S. Of all patients that receive surgery to remove this cancer, about 70% will return to the physician's office with more tumors. This is psychologically devastating for the patient and makes the cancer of the bladder one of the most expensive to treat.

To make things worse, currently there is a worldwide shortage of Bacillus Calmette-Guerin, a bacterium used to make the preferred immunotherapy for decreasing bladder cancer recurrence after surgery. This situation has left doctors struggling to meet the needs of their patients. Therefore, there is a clear need for more effective strategies to treat bladder cancer.

Anthrax Comes to the Rescue

Years ago scientists in the Collier lab modified the anthrax toxin by physically linking it to a naturally occurring protein called the epidermal growth factor (EGF) that binds to the EGF receptor, which is abundant on the surface of bladder cancer cells. When the EGF protein binds to the receptor – like a key fits a lock – it causes the cell to engulf the EGF-anthrax toxin, which then induces the cancer cell to commit suicide (a process called apoptosis), while leaving healthy cells alone.

In collaboration with colleagues at Indiana University medical school, Harvard University and MIT, we designed a strategy to eliminate tumors using this modified toxin. Together we demonstrated that this novel approach allowed us to eliminate tumor cells taken from human, dog and mouse bladder cancer.

This highlights the potential of this agent to provide an efficient and fast alternative to the current treatments (which can take between two and three hours to administer over a period of months). I also think it is good news is that the modified anthrax toxin spared normal cells. This suggests that this treatment could have fewer side effects.

Helping Our Best Friends

These encouraging results led my lab to join forces with Dr. Knapp's group at the Purdue veterinary hospital to treat pet dogs suffering from bladder cancer.

Canine patients for whom all available conventional anti-cancer therapeutics were unsuccessful were considered eligible for these tests. Only after standard tests proved the agent to be safe in laboratory animals, and with the consent of their owners, six eligible dogs with terminal bladder cancer were treated with the anthrax toxin-derived agent.

Two to five doses of this medicine, delivered directly inside the bladder via a catheter, was enough to shrink the tumor by an average of 30%. We consider these results impressive given the initial large size of the tumor and its resistance to other treatments.

There Is Hope for All

Our collaborators at Indiana University Hospital surgically removed bladder cells from human patients and sent them to my lab for testing the agent. At Purdue my team found these cells to be very sensitive to the anthrax toxin-derived agent as well. These results suggest that this novel anti-bladder cancer strategy could be effective in human patients.

The treatment strategy that we have devised is still experimental. Therefore, it is not available for treatment of human patients yet. Nevertheless, my team is actively seeking the needed economic support and required approvals to move this therapeutic approach into human clinical trials. Plans to develop a new, even better generation of agents and to expand their application to the fight against other cancers are ongoing.

R. Claudio Aguilar is an associate professor of biological sciences at Purdue University.
Disclosure statement: R. Claudio Aguilar received funding from National Institutes of Health.

Reposted with permission from The Conversation.

EcoWatch Daily Newsletter

A scenic view of West Papua. Reza Fakhrudin / Pexels

By Arkilaus Kladit

My name is Arkilaus Kladit. I'm from the Knasaimos-Tehit tribe in South Sorong Regency, West Papua Province, Indonesia. For decades my tribe has been fighting to protect our forests from outsiders who want to log it or clear it for palm oil. For my people, the forest is our mother and our best friend. Everything we need to survive comes from the forest: food, medicines, building materials, and there are many sacred sites in the forest.

Read More Show Less
Everyone overthinks their lives or options every once in a while. Some people, however, can't stop the wheels and halt their train of thoughts. Peter Griffith / Getty Images

By Farah Aqel

Overthinkers are people who are buried in their own obsessive thoughts. Imagine being in a large maze where each turn leads into an even deeper and knottier tangle of catastrophic, distressing events — that is what it feels like to them when they think about the issues that confront them.

Read More Show Less
A newly developed catalyst would transform carbon dioxide from power plants and other sources into ethanol. DWalker44 / E+ / Getty Images

Researchers at the Department of Energy's Argonne National Laboratory have discovered a cheap, efficient way to convert carbon dioxide into liquid fuel, potentially reducing the amount of new carbon dioxide pumped into the atmosphere.

Read More Show Less
Eureka Sound on Ellesmere Island in the Canadian Arctic taken by NASA's Operation IceBridge in 2014. NASA / Michael Studinger / Flickr / CC by 2.0

A 4,000-year-old ice shelf in the Canadian Arctic has collapsed into the sea, leaving Canada without any fully intact ice shelves, Reuters reported. The Milne Ice Shelf lost more than 40 percent of its area in just two days at the end of July, said researchers who monitored its collapse.

Read More Show Less
Teachers and activists attend a protest hosted by Chicago Teachers Union in Chicago, Illinois on Aug. 3, 2020 to demand classroom safety measures as schools debate reopening. KAMIL KRZACZYNSKI / AFP via Getty Images

The coronavirus cases surging around the U.S. are often carried by kids, raising fears that the reopening of schools will be delayed and calling into question the wisdom of school districts that have reopened already.

Read More Show Less
Prime Minister Jacinda Ardern holds up COVID-19 alert levels during a press conference at Parliament on March 21, 2020 in Wellington, New Zealand. Hagen Hopkins / Getty Images

By Michael Baker, Amanda Kvalsvig and Nick Wilson

On Sunday, New Zealand marked 100 days without community transmission of COVID-19.

Read More Show Less

Trending

Medics with Austin-Travis County EMS transport a nursing home resident with coronavirus symptoms on Aug. 3, 2020 in Austin, Texas. John Moore / Getty Images

The U.S. passed five million coronavirus cases on Sunday, according to data from Johns Hopkins University, just 17 days after it hit the four-million case mark.

Read More Show Less